Related Experiment Videos

Hormonal therapy in early and advanced breast cancer

Aman U Buzdar1

  • 1The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA.

The Breast Journal
|February 27, 2004
PubMed

Insights

Hormonal therapy for breast cancer is evolving. Aromatase inhibitors (AIs) and other agents like tamoxifen are being sequenced for improved treatment outcomes in diverse patient groups.

Area of Science:

  • Oncology
  • Endocrinology
  • Pharmacology

Background:

  • Aromatase inhibitors (AIs) represent a significant advancement in hormonal therapy for breast cancer.
  • Direct comparative trials of different AIs are limited, with the Arimidex, Tamoxifen, Alone or in Combination (ATAC) trial being a notable exception.

Purpose of the Study:

  • To propose an optimal sequence of hormonal therapies for breast cancer treatment.
  • To integrate findings from the ATAC trial and other AI investigations.

Main Methods:

  • Analysis of data from the ATAC trial.
  • Review of previous investigations on various aromatase inhibitors and other hormonal agents.

Main Results:

  • Emerging evidence suggests a potential sequence for hormonal therapies.
  • The proposed sequence considers different patient populations and treatment histories.

Conclusions:

  • A structured approach to hormonal therapy sequencing is becoming clearer.
  • This evolving strategy aims to optimize breast cancer treatment outcomes using agents like anastrozole, tamoxifen, letrozole, fulvestrant, and megestrol acetate.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.